Valuation: ATON

Market Cap 59.62L 68.12L 55L 51.37L 96.77L 64Cr 98.84L 6.61Cr 2.56Cr 32Cr 2.56Cr 2.5Cr 110.29Cr P/E 2023
-0.45x
P/E 2024 -4.95x
Enterprise Value 1.05Cr 1.2Cr 97.15L 90.74L 1.71Cr 113.78Cr 1.75Cr 12Cr 4.52Cr 56Cr 4.52Cr 4.42Cr 194.8Cr EV / Sales 2023
28.9x
EV / Sales 2024 20.3x
Free-Float
75.06%
Yield 2023 *
-
Yield 2024 -
1 week-22.22%
Current month-28.57%
1 month-12.50%
3 months+600.00%
6 months+84.21%
Current year+66.67%
1 week 0
Extreme 0.0044
0.01
1 month 0
Extreme 0.0044
0.01
Current year 0
Extreme 0.0002
0.03
1 year 0
Extreme 0.0002
0.03
3 years 0
Extreme 0.0002
0.05
5 years 0
Extreme 0.0002
0.2
10 years 0
Extreme 0.0002
0.83
Manager TitleAgeSince
Chief Executive Officer - 06/01/2022
Corporate Officer/Principal - 18/02/2026
Director TitleAgeSince
Chairman - 20/12/2023
Director/Board Member - 21/09/2021
Director/Board Member - 20/12/2023
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-22.22% - - 1.13Cr
-1.29%+9.00%+24.04%-0.73% 19TCr
+0.31%-0.20%-23.93%+21.92% 14TCr
-1.74%+8.81%-3.03%-17.89% 14TCr
-1.70%-4.00%-59.19%-18.65% 6.57TCr
+0.44%+4.37%+16.58%+0.82% 5.23TCr
-0.47%-0.50%-27.38%-32.98% 4.35TCr
-2.34%+4.54%+11.46%+14.14% 3.84TCr
-1.48%+3.78%+4.67%+43.28% 3.68TCr
-1.08%+5.62%-12.54%-15.73% 2.99TCr
Average -0.93%+4.59%-7.70%-0.65% 8.22TCr
Weighted average by Cap. -0.99%+5.58%-4.39%-0.59%

Financials

2023 2024
Net sales 4L 4L 4L 3L 6L 4.13Cr 6L 42.39L 16.38L 2.04Cr 16.39L 16.03L 7.07Cr 6L 7L 6L 5L 10L 6.63Cr 10.18L 68.1L 26.33L 3.27Cr 26.33L 25.76L 11Cr
Net income -1.88Cr -2.15Cr -1.74Cr -1.62Cr -3.06Cr -203.61Cr -3.12Cr -21Cr -8.08Cr -100.44Cr -8.08Cr -7.91Cr -348.61Cr -11.01L -12.58L -10.16L -9L -17.87L -12Cr -18.25L -1.22Cr -47.21L -5.87Cr -47.22L -46.19L -20Cr
Net Debt 32.41L 37.02L 29.89L 27.92L 52.6L 35Cr 53.72L 3.59Cr 1.39Cr 17Cr 1.39Cr 1.36Cr 60Cr 45.69L 52.2L 42.15L 39.37L 74.16L 49Cr 75.74L 5.07Cr 1.96Cr 24Cr 1.96Cr 1.92Cr 85Cr
Logo ATON
ATON is a medical science group committed to the future of medicine, with the aim of improving patient care and the safety and efficacy of treatments. ATON guides and develops a portfolio of cutting-edge companies, each with its own specialty, working in synergy to advance the medicine of today and tomorrow.
Employees
9
Date Price Change
29/26/29 €0.007000 0.00%
26/26/26 €0.007000 +59.09%
25/26/25 €0.004400 0.00%
24/26/24 €0.004400 -12.00%
23/26/23 €0.005000 -13.79%